ST7-FOXP2 Fusion FISH Probe
The ST7-FOXP2 Fusion FISH Probe is used to confirm a fusion of the ST7 and FOXP2 genes. The fusion of the ST7 and FOXP2 genes has been associated with Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
ST7-FOXP2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-RERE | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-REOR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-REGO | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-REGR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-REAQ | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-ORRE | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-OROR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-ORGO | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-ORAQ | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GORE | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GOOR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GOGO | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GOGR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GOAQ | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GRRE | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GROR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GRGO | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GRGR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-GRAQ | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-AQRE | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-AQOR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-AQGO | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-AQGR | 20 (40 μL) | 200 μL | ||
ST7-FOXP2-20-AQAQ | 20 (40 μL) | 200 μL |
ST7 Gene Summary
The gene for this product maps to a region on chromosome 7 identified as an autism-susceptibility locus. Mutation screening of the entire coding region in autistic individuals failed to identify phenotype-specific variants, suggesting that coding mutations for this gene are unlikely to be involved in the etiology of autism. The function of this gene product has not been determined. Transcript variants encoding different isoforms of this protein have been described. [provided by RefSeq, Jul 2008]
Gene Name: Suppression Of Tumorigenicity 7
Chromosome: CHR7: 116593380 -116870075
Locus: 7q31.2
FOXP2 Gene Summary
This gene encodes a member of the forkhead/winged-helix (FOX) family of transcription factors. It is expressed in fetal and adult brain as well as in several other organs such as the lung and gut. The protein product contains a FOX DNA-binding domain and a large polyglutamine tract and is an evolutionarily conserved transcription factor, which may bind directly to approximately 300 to 400 gene promoters in the human genome to regulate the expression of a variety of genes. This gene is required for proper development of speech and language regions of the brain during embryogenesis, and may be involved in a variety of biological pathways and cascades that may ultimately influence language development. Mutations in this gene cause speech-language disorder 1 (SPCH1), also known as autosomal dominant speech and language disorder with orofacial dyspraxia. Multiple alternative transcripts encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
Gene Name: Forkhead Box P2
Chromosome: CHR7: 113726364 -114333827
Locus: 7q31.1
Gene Diseases
The ST7 FOXP2 Fusion has been associated with the following diseases:
Disease Name |
---|
Liver Hepatocellular Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|